首页> 美国卫生研究院文献>World Journal of Gastroenterology >Purification and characterization of 33.5 kDa vesicular protein in human bile
【2h】

Purification and characterization of 33.5 kDa vesicular protein in human bile

机译:人胆汁中33.5 kDa囊泡蛋白的纯化和鉴定

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

AIM: The present study was undertaken to purify and partially characterize the 33.5-kilodalton (33.5 kDa) vesicular protein in human bile and to explore the possible molecular mechanisms of the initial crystal nucleation process.METHODS: The 33.5 kDa vesicular protein was isolated by ultracentrifugation and further purified by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) under nonreducing conditions. The purified 33.5 kDa vesicular protein was subjected to N-terminal amino acid sequencing and amino acid analysis. Cholesterol crystallization activity was detected by cholesterol crystal growth assay. The sugar chain of the 33.5 kDa vesicular protein was analyzed by dot-immunobinding assay of lectin coupled to a peroxidase (HRP-DSA, HRP-ConA, HRP-WGA) and was deglycosylated using two different enzymatic approaches (N-deglycosylation and O-deglycosylation) to determine the molecular weight of the protein component, the type of linkage between polypeptide and carbohydrate components.RESULTS: The 33.5 kDa vesicular protein with complicated glycan was an extensively glycosylated (37.3%) monomer and these sugar chains strongly bound to DSA, but did not bind to ConA. Amino acid sequencing indicated that the protein was unique. The 33.5 kDa vesicular protein exhibited potent cholesterol crystallization promoting activity in vitro with derived crystal growth curve indices It, Ig, Ic presented as 0.57, 1.52, and 1.63 respectively. Both enzymatic proteolysis and N-deglycosylation of the protein removed all activity.CONCLUSION: These data suggest the 33.5 kDa vesicular protein may be responsible for the pathogenesis of cholesterol gallstone disease, and the sugar chains play an important role in pro-nucleating process.
机译:目的:进行本研究以纯化和部分鉴定人胆汁中的33.5-千达尔顿(33.5 kDa)囊泡蛋白,并探讨初始晶体成核过程的可能分子机制。方法:通过超速离心分离33.5 kDa囊泡蛋白。然后在非还原条件下通过十二烷基硫酸钠-聚丙烯酰胺凝胶电泳(SDS-PAGE)进一步纯化。对纯化的33.5kDa囊泡蛋白进行N端氨基酸测序和氨基酸分析。通过胆固醇晶体生长测定法检测胆固醇的结晶活性。通过与过氧化物酶(HRP-DSA,HRP-ConA,HRP-WGA)偶联的凝集素的斑点免疫结合测定法分析了33.5 kDa囊泡蛋白的糖链,并使用两种不同的酶促方法(N-去糖基化和O-结果:33.5 kDa的囊泡蛋白具有复杂的聚糖,是一个广泛糖基化的单体(37.3%),这些糖链与DSA牢固结合,但未绑定到ConA。氨基酸测序表明该蛋白质是独特的。 33.5 kDa的囊泡蛋白在体外显示出有效的胆固醇结晶促进活性,导出的晶体生长曲线指数It,Ig,Ic分别为0.57、1.52和1.63。结论:这些数据表明,33.5 kDa的囊泡蛋白可能是胆固醇胆结石病的发病机制,糖链在促成核过程中起着重要作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号